$78.9 Million is the total value of Blackcrane Capital, LLC's 9 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NICE | Buy | NICE LTD - SPON ADRsponsored adr | $14,292,000 | +93.2% | 104,320 | +72.8% | 18.12% | +83.4% |
| FTI | Buy | TECHNIPFMC PLC | $11,337,000 | +86.2% | 441,092 | +69.3% | 14.37% | +76.7% |
| GWRE | Buy | GUIDEWIRE SOFTWARE INC | $6,536,000 | +4.4% | 64,474 | +0.1% | 8.29% | -0.8% |
| HOLI | New | HOLLYSYS AUTOMATION TECHNOLO | $6,246,000 | – | 328,753 | +100.0% | 7.92% | – |
| AKTS | New | AKOUSTIS TECHNOLOGIES INC | $4,440,000 | – | 693,719 | +100.0% | 5.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.